UPDATE: Piper Sandler Downgrades NovoCure Ltd. (NVCR) to Neutral

October 24, 2022 3:50 AM EDT Send to a Friend
(Updated - October 24, 2022 6:30 AM EDT)

Piper Sandler analyst Jason Bednar downgraded NovoCure Ltd. (NASDAQ: NVCR) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login